Template:CMV neurologic disease treatment: Difference between revisions
Ostermayer (talk | contribs) (Prepared the page for translation) |
Ostermayer (talk | contribs) (Marked this version for translation) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
<languages/> | <noinclude><languages/></noinclude> | ||
<translate> | <translate> | ||
<!--T:1--> | |||
*[[Special:MyLanguage/Ganciclovir|Ganciclovir]] 5mg/kg IV q12hrs daily x 21 days FOLLOWED BY 5mg/kg IV q24hrs + | *[[Special:MyLanguage/Ganciclovir|Ganciclovir]] 5mg/kg IV q12hrs daily x 21 days FOLLOWED BY 5mg/kg IV q24hrs + | ||
**[[Special:MyLanguage/Foscarnet|Foscarnet]] 90mg/kg IV q12hrs x 21 days THEN 90-120mg/kg IV q24hrs | **[[Special:MyLanguage/Foscarnet|Foscarnet]] 90mg/kg IV q12hrs x 21 days THEN 90-120mg/kg IV q24hrs | ||
</translate> | </translate> | ||
Latest revision as of 06:28, 26 January 2026
- Ganciclovir 5mg/kg IV q12hrs daily x 21 days FOLLOWED BY 5mg/kg IV q24hrs +
- Foscarnet 90mg/kg IV q12hrs x 21 days THEN 90-120mg/kg IV q24hrs